WHO ICTRP trial
Study of the Rivaroxaban 10mg on Tunneled cuffed catheter patency
IRCT20211026052874N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20211026052874N1 |
|---|---|
| Public title | Study of the Rivaroxaban 10mg on Tunneled cuffed catheter patency |
| Scientific title | Study of the Rivaroxaban 10mg on Tunneled cuffed catheter patency in hemodialysis patients |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Dysfunctional cuffed tunneled dialysis catheter. |
| Interventions | Intervention 1: Intervention group: Dialysis patients with a tunneled cuffed catheter are given one 10 mg rivaroxaban tablet daily. Patients are followed up at one, three, and six month intervals, and the number of catheter dysfunctions due… |
| Registration date | Jan 11, 2025 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: